en
Scientific article
Open access
English

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

Published inAlzheimer's & dementia, vol. 5, p. 933-938
Publication date2019
Abstract

Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers.

Keywords
  • Alzheimer's disease
  • Biomarkers
  • EMIF-AD
  • Machine-Learning
  • Metabolomics
Funding
  • European Commission - European Medical Information Framework [115372]
Citation (ISO format)
STAMATE, Daniel et al. A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort. In: Alzheimer’s & dementia, 2019, vol. 5, p. 933–938. doi: 10.1016/j.trci.2019.11.001
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal2352-8737
287views
93downloads

Technical informations

Creation07/10/2020 1:26:00 PM
First validation07/10/2020 1:26:00 PM
Update time03/15/2023 10:31:15 PM
Status update03/15/2023 10:31:12 PM
Last indexation08/30/2023 11:24:43 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack